Assess the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Meropenem-Pralubactam (Meropenem/FL058) in China Healthy Adult Participants
Clinical trial NCT07124468 · RECRUITING
Trial details
- NCT number
- NCT07124468
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-13
- Primary completion
- 2025-12-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.